Literature DB >> 25938395

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+ CD45RB high T Cells into Immunodeficient Mice.

Erin C Steinbach1, Gregory R Gipson2, Shehzad Z Sheikh3.   

Abstract

There are many different animal models available for studying the pathogenesis of human inflammatory bowel diseases (IBD), each with its own advantages and disadvantages. We describe here an experimental colitis model that is initiated by adoptive transfer of syngeneic splenic CD4(+)CD45RB(high) T cells into T and B cell deficient recipient mice. The CD4(+)CD45RB(high) T cell population that largely consists of naïve effector cells is capable of inducing chronic intestinal inflammation, closely resembling key aspects of human IBD. This method can be manipulated to study aspects of disease onset and progression. Additionally it can be used to study the function of innate, adaptive, and regulatory immune cell populations, and the role of environmental exposures, i.e., the microbiota, in intestinal inflammation. In this article we illustrate the methodology for inducing colitis with a step-by-step protocol. This includes a video demonstration of key technical aspects required to successfully develop this murine model of experimental colitis for research purposes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25938395      PMCID: PMC4541583          DOI: 10.3791/52533

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  23 in total

Review 1.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

2.  Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.

Authors:  M W Leach; A G Bean; S Mauze; R L Coffman; F Powrie
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.

Authors:  Fengjun Wang; Brad T Schwarz; W Vallen Graham; Yingmin Wang; Liping Su; Daniel R Clayburgh; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2006-08-22       Impact factor: 22.682

4.  Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.

Authors:  Makoto Naganuma; Elizabeth B Wiznerowicz; Courtney M Lappas; Joel Linden; Mark T Worthington; Peter B Ernst
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Carboxylated glycans mediate colitis through activation of NF-kappa B.

Authors:  Geetha Srikrishna; Olga Turovskaya; Raziya Shaikh; Robbin Newlin; Dirk Foell; Simon Murch; Mitchell Kronenberg; Hudson H Freeze
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

6.  NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity.

Authors:  Taku Kobayashi; Katsuyoshi Matsuoka; Shehzad Z Sheikh; Houda Z Elloumi; Nobuhiko Kamada; Tadakazu Hisamatsu; Jonathan J Hansen; Kevin R Doty; Scott D Pope; Stephen T Smale; Toshifumi Hibi; Paul B Rothman; Masaki Kashiwada; Scott E Plevy
Journal:  J Immunol       Date:  2011-03-07       Impact factor: 5.422

7.  The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

Authors:  Masayuki Fukata; Keith Breglio; Anli Chen; Arunan S Vamadevan; Tyralee Goo; David Hsu; Daisy Conduah; Ruliang Xu; Maria T Abreu
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

8.  Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells.

Authors:  S Read; F Powrie
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 9.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

10.  The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Authors:  Michel H Maillard; Vinicius Cotta-de-Almeida; Fuminao Takeshima; Deanna D Nguyen; Pierre Michetti; Cathryn Nagler; Atul K Bhan; Scott B Snapper
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

View more
  4 in total

1.  Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses.

Authors:  Jeremy M Simon; James P Davis; Saangyoung E Lee; Matthew R Schaner; Gregory R Gipson; Matthew Weiser; R Balfour Sartor; Hans H Herfarth; Reza Rahbar; Timothy S Sadiq; Mark J Koruda; Dermot P McGovern; Jason D Lieb; Karen L Mohlke; Terrence S Furey; Shehzad Z Sheikh
Journal:  Eur J Immunol       Date:  2016-06-01       Impact factor: 5.532

2.  The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth.

Authors:  Siqi Chen; Imran Akdemir; Jie Fan; Joel Linden; Bin Zhang; Caglar Cekic
Journal:  Cancer Immunol Res       Date:  2020-05-07       Impact factor: 12.020

3.  Early Detection of T cell Transfer-induced Autoimmune Colitis by In Vivo Imaging System.

Authors:  Yu-Ling Chen; Yi-Ting Chen; Cheng-Feng Lo; Ching-I Hsieh; Shang-Yi Chiu; Chang-Yen Wu; Yu-Shan Yeh; Shu-Hsuan Hung; Po-Hao Cheng; Yu-Hsuan Su; Si-Tse Jiang; Hsian-Jean Chin; Yu-Chia Su
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

4.  E-cadherin activating antibodies limit barrier dysfunction and inflammation in mouse inflammatory bowel disease.

Authors:  Chirosree Bandyopadhyay; Leslayann Schecterson; Barry M Gumbiner
Journal:  Tissue Barriers       Date:  2021-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.